Voya Investment Management LLC Mirati Therapeutics, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $700,897 - $1.04 Million	-16,692 Reduced 70.89%	6,853 $402,000
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $834 - $1,360	-30 Reduced 0.13%	23,545 $1.03 Million
Q2 2023 Aug 14, 2023	BUY	$36.13 - $49.49 $4,985 - $6,829	138 Added 0.59%	23,575 $851,000
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $3,325 - $4,937	-91 Reduced 0.39%	23,437 $871,000
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $773,482 - $1.85 Million	-18,742 Reduced 44.34%	23,528 $1.07 Million
Q3 2022 Mar 03, 2023	BUY	$59.5 - $86.7 $1.12 Million - $1.62 Million	18,742 Added 79.66%	42,270 $2.95 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $2.18 Million - $3.18 Million	36,637 Added 650.4%	42,270 $2.95 Million
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $481,589 - $1.09 Million	-12,298 Reduced 68.59%	5,633 $378,000
Q1 2022 May 16, 2022	SELL	$75.82 - $150.97 $25,475 - $50,725	-336 Reduced 1.84%	17,931 $1.47 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $909,680 - $1.31 Million	6,891 Added 60.57%	18,267 $2.68 Million
Q3 2021 Nov 15, 2021	SELL	$132.13 - $177.45 $28,672 - $38,506	-217 Reduced 1.87%	11,376 $2.01 Million
Q2 2021 Aug 16, 2021	SELL	$144.0 - $179.73 $14.8 Million - $18.5 Million	-103,032 Reduced 89.89%	11,593 $1.87 Million
Q1 2021 May 17, 2021	BUY	$158.92 - $221.61 $2.33 Million - $3.25 Million	14,643 Added 14.65%	114,625 $19.6 Million
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $14.1 Million - $21 Million	87,292 Added 687.88%	99,982 $22 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $136,963 - $228,981	-1,902 Reduced 13.03%	12,690 $1.45 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $70,966 - $118,185	1,017 Added 7.49%	14,592 $1.12 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $208,954 - $380,523	2,953 Added 27.8%	13,575 $1.75 Million
Q3 2019 Nov 14, 2019	BUY	$77.91 - $109.6 $54,770 - $77,048	703 Added 7.09%	10,622 $828,000
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $81,917 - $144,185	1,377 Added 16.12%	9,919 $1.02 Million
Q1 2019 May 15, 2019	BUY	$43.65 - $78.95 $4,408 - $7,973	101 Added 1.2%	8,542 $626,000
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $20,480 - $30,355	640 Added 8.2%	8,441 $358,000
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $36,361 - $48,404	772 Added 10.98%	7,801 $367,000
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $183,105 - $368,319	7,029 New	7,029 $347,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account